Search - tctmd.com

Displaying 1 - 20 of 25

Sort: Relevancy | Date

News Daily News

FDA Approves Aficamten for Obstructive HCM

L.A. McKeown

December 29, 2025

News Conference News ESC 2025

Boosting Potassium Helps Patients at High Risk for Ventricular Arrhythmias

Todd Neale

August 29, 2025

No Change in HF Outcomes When Private Equity Buys the Hospital

News Daily News

Private Equity-Backed Hospitals Appear to 'Cherry-Pick' HF Patients

Michael O'Riordan

June 16, 2025

News Conference News ESC Heart Failure 2025

Finerenone May Cut Early Readmissions in HF Patients

Todd Neale

May 21, 2025

News Opinion CV Team Dispatch

December 2024 Dispatch for the CV Team

L.A. McKeown

December 20, 2024

News Daily News

HFSA Stats 2024 a ‘Call to Action’ Against Rising Tide of HF

L.A. McKeown

October 01, 2024

News Daily News

Subcutaneous Furosemide Enables HF Patients to Address Congestion at Home

Caitlin E. Cox

September 16, 2024

News Daily News

Aligning Pill Burden and Palliative Care Needs in Late-Stage CVD: AHA

L.A. McKeown

July 02, 2024

News Daily News

Semaglutide Has Similar Benefits in Women and Men With HFpEF

Todd Neale

June 26, 2024

News Conference News NY Valves 2024

Polymer Mitral Valve Shows Well Early, but Long-term Data Key

Michael O'Riordan

June 12, 2024

News Opinion CV Team Dispatch

November 2023 News Roundup

L.A. McKeown

November 01, 2023

News Opinion CV Team Dispatch

October 2023 News Roundup

L.A. McKeown

October 01, 2023

News Conference News ESC Heart Failure 2023

SGLT2i Still Underprescribed in HFrEF, New US Analysis Confirms

L.A. McKeown

June 06, 2023

News Opinion CV Team Dispatch

June 2023 News Roundup

L.A. McKeown

June 01, 2023

News Conference News ESC Heart Failure 2023

Could Copper Chelation Benefit HFrEF? TRACER-HF Offers Mixed Clues

Shelley Wood

May 25, 2023

News Daily News

New Expert Consensus Papers Aim to Boost Management, Outcomes in HFpEF

L.A. McKeown

April 19, 2023

News Daily News

Top Heart Failure News of 2022

Shelley Wood

January 04, 2023

News Daily News

FDA Approves Mavacamten for Obstructive Hypertrophic Cardiomyopathy

Michael O'Riordan

April 29, 2022

News Daily News

In the US, HF Prevalence—and Costs—Rising Steeply: HFSA Report

Michael O'Riordan

January 27, 2022

News Opinion CV Team Dispatch

December 2021 News Roundup

L.A. McKeown

December 01, 2021

Advertisement

FDA Approves Aficamten for Obstructive HCM

Boosting Potassium Helps Patients at High Risk for Ventricular Arrhythmias

Private Equity-Backed Hospitals Appear to 'Cherry-Pick' HF Patients

Finerenone May Cut Early Readmissions in HF Patients

December 2024 Dispatch for the CV Team

HFSA Stats 2024 a ‘Call to Action’ Against Rising Tide of HF

Subcutaneous Furosemide Enables HF Patients to Address Congestion at Home

Aligning Pill Burden and Palliative Care Needs in Late-Stage CVD: AHA

Semaglutide Has Similar Benefits in Women and Men With HFpEF

Polymer Mitral Valve Shows Well Early, but Long-term Data Key

November 2023 News Roundup

October 2023 News Roundup

SGLT2i Still Underprescribed in HFrEF, New US Analysis Confirms

June 2023 News Roundup

Could Copper Chelation Benefit HFrEF? TRACER-HF Offers Mixed Clues

New Expert Consensus Papers Aim to Boost Management, Outcomes in HFpEF

Top Heart Failure News of 2022

FDA Approves Mavacamten for Obstructive Hypertrophic Cardiomyopathy

In the US, HF Prevalence—and Costs—Rising Steeply: HFSA Report

December 2021 News Roundup

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content